The natural history of recurrent hepatitis C and what influences this.
about
Current management and perspectives for HCV recurrence after liver transplantationStrategies to reduce hepatitis C virus recurrence after liver transplantationPre- and Post-Transplant Antiviral Therapy (HBV, HCV)Role of liver transplantation in human immunodeficiency virus positive patientsEra of direct acting antivirals in chronic hepatitis C: Who will benefit?Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug ResistanceManagement of Hepatitis C Post-liver Transplantation: a Comprehensive ReviewHepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and ManagementImpact of new treatment options for hepatitis C virus infection in liver transplantationΜanagement of patients with hepatitis B and C before and after liver and kidney transplantationUltrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysisImportance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational toleranceRecommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National GuidelineManagement of hepatitis C infection before and after liver transplantationRecent advances in liver transplantation for the practicing gastroenterologistPrimary liver transplantation and liver retransplantation: comparison of health-related quality of life and mental status - a cross-sectional study.Distinct features in natural history and outcomes of acute hepatitis C.The association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients.Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review.Human liver transplantation as a model to study hepatitis C virus pathogenesisManagement of recurrent hepatitis C following liver transplantation.Innate immune cell networking in hepatitis C virus infectionThe effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis CRapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection.Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.Management of viral hepatitis in liver transplant recipientsInhibitors of peptidyl proline isomerases as antivirals in hepatitis C and other viruses.Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.Review on immunosuppression in liver transplantation.Predictive factors associated with hepatitis C antiviral therapy response.Hepatitis C genotype influences post-liver transplant outcomesPost-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on OutcomesLong-Term Outcomes of Simultaneous Liver-Kidney Transplant Patients with Hepatitis B Compared to with Liver Transplant Alone.Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallateTwo-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy.Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient.Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients.
P2860
Q22299427-6AF8B09A-B3EF-450E-81B5-90451EC9C805Q22305418-AFB73EC9-A5BC-4B7C-B5B4-0E648CDF8102Q26740319-0ABDC725-E2A9-4050-AB55-AB802F3A3730Q26775931-A8686299-0DE9-4140-92FB-A0C5D69A56B5Q26777506-ED1E9114-967D-4738-93D6-3409B9BAB0A3Q26781331-DD80B180-811E-4236-B043-8DABD02E7E80Q26781741-350DC032-F995-4B10-9EF6-0778AF4C8F7DQ26781984-F4FD186E-BC36-40C3-8658-31026B07780DQ26782017-1BA777FA-431E-4A8A-9DCB-86A56FD946D6Q26864647-77E64181-DEFA-4EA2-A6BD-F68920B3D53BQ27021373-3B59EF3D-1251-471A-8254-7C6728AC1C77Q27026283-10EF339D-9A7B-46E2-8122-0FA4F7977488Q28076883-1BD6E96C-AC09-4EB5-85D3-EF320C90462FQ28081250-1473CDD0-1DBF-4160-948A-7157E7F86949Q33916188-9FD72262-118C-46AF-9EB2-3BBE3A0F8675Q33922588-4B6FFB13-E04E-4C19-818E-0BE3F7A8FA1BQ33955210-9FFA835F-4553-4183-A4D9-22EFA44F34BDQ34081261-F57429C3-0291-45B5-85AC-71D7F28434D8Q34093754-C26B0D2F-201A-4F3C-ACBF-B245A9353397Q34150039-D9A73567-C2ED-4788-899F-C88CC1716A6FQ34197528-EA4A7195-0C84-4E70-951A-9159282EF526Q34298333-8141A789-D72A-4613-9879-0704596415F9Q34341382-B93DE8D3-DBAF-47AA-88E2-884B53F81B87Q34398332-C5C794B4-2A9D-49A0-B3C4-3708060C0E0EQ34522213-D5EDACAA-9479-40FD-9A39-88C59EC75160Q34684679-D6759998-9952-4376-A1F5-8A0CB3889864Q34779730-1E6FC9DF-F956-4310-9700-AC158775D061Q35400246-034955F1-D7B8-4B65-A73E-6923549433D1Q35570778-D1647308-A7A1-4984-AE06-B532C281FBDFQ35668757-1A79FC6A-4685-428D-A9F2-835908D30E84Q35790397-79AD3AD1-70F5-4BCC-81FB-F00608F6FFF3Q36354472-599FC2B1-E730-4251-93B0-3AB1F50C2546Q36541052-B7B5F1F0-B418-45A1-AF9E-B77E31560DFCQ36551248-435E4F56-F22A-42C7-9EB4-A1F632916267Q36624431-3F60B4F3-C801-4488-9B5D-9B4BE7D6B55BQ36855565-6A6D03B7-BDAB-40FE-815D-A165A8578D54Q36875036-E535FB87-396E-457B-8C70-5059977BA361Q36968819-82A23DDD-F97A-4879-BE1C-4408DA7153E1Q36979114-A4E9CD24-8E1F-4298-98FE-4B8D82E1824DQ36997118-969D955D-3B7E-4637-8EBC-7A0909A6FC3C
P2860
The natural history of recurrent hepatitis C and what influences this.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The natural history of recurrent hepatitis C and what influences this.
@en
The natural history of recurrent hepatitis C and what influences this.
@nl
type
label
The natural history of recurrent hepatitis C and what influences this.
@en
The natural history of recurrent hepatitis C and what influences this.
@nl
prefLabel
The natural history of recurrent hepatitis C and what influences this.
@en
The natural history of recurrent hepatitis C and what influences this.
@nl
P2860
P356
P1476
The natural history of recurrent hepatitis C and what influences this.
@en
P2093
Edward J Gane
P2860
P304
P356
10.1002/LT.21646
P478
14 Suppl 2
P577
2008-10-01T00:00:00Z